Skip to main content

Advertisement

SpringerLink
Log in

Impact of minimum contrast media volumes during percutaneous coronary intervention for chronic total occlusion lesion

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

Contrast media exposure is associated with contrast-induced nephropathy (CIN) following percutaneous coronary intervention (PCI) of chronic total occlusion (CTO). Aim of this study is to assess the utility of minimum contrast media volume (CMV ≤ 50 mL) during CTO-PCI for CIN prevention in patients with chronic kidney disease (CKD). We extracted data from the Japanese CTO-PCI expert registry; 2863 patients with CKD who underwent CTO-PCI performed from 2014 to 2020 were divided into two groups: minimum CMV (n = 191) and non-minimum CMV groups (n = 2672). CIN was defined as an increased serum creatinine level of ≥ 25% and/or ≥ 0.5 mg/dL compared with baseline levels within 72 h of the procedure. In the minimum CMV group, the CIN incidence was lower than that in the non-minimum CMV group (1.0% vs. 4.1%; p = 0.03). Patient success rate was higher and complication rate was lower in the minimum CMV group than in the non-minimum CMV group (96.8% vs. 90.3%; p = 0.02 and 3.1% vs. 7.1%; p = 0.03). In the minimum CMV group, the primary retrograde approach was more frequent in the case of J-CTO = 1,2 and 3–5 groups compared to that in non-minimum CMV-PCI group (J-CTO = 0; 11% vs. 17.7%, p = 0.06; J-CTO = 1; 22% vs. 35.8%, p = 0.01; J-CTO = 2; 32.4% vs. 46.5%, p = 0.01; and J-CTO = 3–5; 44.7% vs. 80.0%, p = 0.02). Minimum CMV-PCI for CTO in CKD patients could reduce the incidence of CIN. The primary retrograde approach was observed to a greater extent in the minimum CMV group, especially in cases of difficult CTO.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Data availability

The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.

References

  1. Tajti P, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW, Burke MN, Doing AH, Dattilo P, Toma C, Smith AJC, Uretsky B, Holper E, Wyman RM, Kandzari DE, Garcia S, Krestyaninov O, Khelimskii D, Koutouzis M, Tsiafoutis I, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Doshi D, Rangan BV, Ungi I, Banerjee S, Brilakis ES (2018) The hybrid approach to chronic total occlusion percutaneous coronary intervention: update from the PROGRESS CTO registry. JACC Cardiovasc Interv 11:1325–1335

    Article  PubMed  Google Scholar 

  2. Tanaka H, Tsuchikane E, Muramatsu T, Kishi K, Muto M, Oikawa Y, Kawasaki T, Hamazaki Y, Fujita T, Katoh O (2019) A novel algorithm for treating chronic total coronary artery occlusion. J Am Coll Cardiol 74:2392–2404

    Article  PubMed  Google Scholar 

  3. Harding SA, Wu EB, Lo S, Lim ST, Ge L, Chen JY, Quan J, Lee SW, Kao HL, Tsuchikane E (2017) A new algorithm for crossing chronic total occlusions from the Asia Pacific chronic total occlusion club. JACC Cardiovasc Interv 10:2135–2143

    Article  PubMed  Google Scholar 

  4. Bartholomew BA, Harjai KJ, Dukkipati S, Boura JA, Yerkey MW, Glazier S, Grines CL, O’Neill WW (2004) Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol 93:1515–1519

    Article  PubMed  Google Scholar 

  5. Patel VG, Brayton KM, Tamayo A, Mogabgab O, Michael TT, Lo N, Alomar M, Shorrock D, Cipher D, Abdullah S, Banerjee S, Brilakis ES (2013) Angiographic success and procedural complications in patients undergoing percutaneous coronary chronic total occlusion interventions: a weighted meta-analysis of 18,061 patients from 65 studies. JACC Cardiovasc Interv 6:128–136

    Article  PubMed  Google Scholar 

  6. Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, Leon MB, Dangas G (2004) A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 44:1393–1399

    PubMed  Google Scholar 

  7. Ebisawa S, Kurita T, Tanaka N, Nasu K, Kimura M, Ito T, Kinoshita Y, Tsuchikane E, Terashima M, Suzuki T (2016) Impact of minimum contrast media volumes during elective percutaneous coronary intervention for prevention of contrast-induced nephropathy in patients with stable coronary artery disease. Cardiovasc Interv Ther 31:13–20

    Article  PubMed  Google Scholar 

  8. Suzuki Y, Tsuchikane E, Katoh O, Muramatsu T, Muto M, Kishi K, Hamazaki Y, Oikawa Y, Kawasaki T, Okamura A (2017) Outcomes of percutaneous coronary interventions for chronic total occlusion performed by highly experienced japanese specialists: The first report from the Japanese CTO-PCI Expert Registry. JACC Cardiovasc Interv 10:2144–2154

    Article  PubMed  Google Scholar 

  9. Morino Y, Abe M, Morimoto T, Kimura T, Hayashi Y, Muramatsu T, Ochiai M, Noguchi Y, Kato K, Shibata Y, Hiasa Y, Doi O, Yamashita T, Hinohara T, Tanaka H, Mitsudo K, J-CTO Registry Investigators (2011) Predicting successful guidewire crossing through chronic total occlusion of native coronary lesions within 30 minutes: the J-CTO (Multicenter CTO Registry in Japan) score as a difficulty grading and time assessment tool. JACC Cardiovasc Interv 4:213–221

    Article  PubMed  Google Scholar 

  10. Lin YS, Fang HY, Hussein H, Fang CY, Chen YL, Hsueh SK, Cheng CI, Yang CH, Chen CJ, Hang CL, Yip HK, Wu CJ (2014) Predictors of contrast-induced nephropathy in chronic total occlusion percutaneous coronary intervention. EuroIntervention 9:1173–1180

    Article  PubMed  Google Scholar 

  11. Pavlidis AN, Jones DA, Sirker A, Mathur A, Smith EJ (2015) Prevention of contrast-induced acute kidney injury after percutaneous coronary intervention for chronic total coronary occlusions. Am J Cardiol 115:844–851

    Article  PubMed  Google Scholar 

  12. Lee PH, Lee SW, Park HS, Kang SH, Bae BJ, Chang M, Roh JH, Yoon SH, Ahn JM, Park DW, Kang SJ, Kim YH, Lee CW, Park SW, Park SJ (2016) Successful recanalization of native coronary chronic total occlusion is not associated with improved long-term survival. JACC Cardiovasc Interv 9:530–538

    Article  PubMed  Google Scholar 

  13. Maeremans J, Dens J, Spratt JC, Bagnall AJ, Stuijfzand W, Nap A, Agostoni P, Wilson W, Hanratty CG, Wilson S, Faurie B, Avran A, Bressollette E, Egred B, Knaapen P, Walsh S, RECHARGE Investigators (2017) Antegrade dissection and reentry as part of the hybrid chronic total occlusion revascularization strategy: a subanalysis of the RECHARGE Registry (Registry of CrossBoss and Hybrid Procedures in France, The Netherlands, Belgium and United Kingdom). Circ Cardiovasc Interv 10:e004791

    Article  PubMed  Google Scholar 

  14. Wu EB, Tsuchikane E, Ge L, Harding SA, Lo S, Lim ST, Chen JY, Lee SW, Qian J, Kao HL, Yan BPY (2019) Retrograde versus antegrade approach for coronary chronic total occlusion in an algorithm-driven contemporary Asia-Pacific multicentre registry: comparison of outcomes. Heart Lung Circ 29(6):894–903

    Article  PubMed  Google Scholar 

  15. Laskey WK, Jenkins C, Selzer F, Marroquin OC, Wilensky RL, Glaser R, Cohen HA, Holmes DR Jr, Dynamic Registry Investigators NHLBI (2007) Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention. J Am Coll Cardiol 50:584–590

    Article  CAS  PubMed  Google Scholar 

  16. Wu EB, Brilakis ES, Mashayekhi K, Tsuchikane E, Alaswad K, Araya M, Avran A, Azzalini L, Babunashvili AM, Bayani B, Behnes M, Bhindi R, Boudou N, Boukhris M, Bozinovic NZ, Bryniarski L, Bufe A, Buller CE, Burke MN, Buttner A, Cardoso P, Carlino M, Chen JY, Christiansen EH, Colombo A, Croce K, de Los Santos FD, de Martini T, Dens J, di Mario C, Dou K, Egred M, Elbarouni B, ElGuindy AM, Escaned J, Furkalo S, Gagnor A, Galassi AR, Garbo R, Gasparini G, Ge J, Ge L, Goel PK, Goktekin O, Gonzalo N, Grancini L, Hall A, Hanna Quesada FL, Hanratty C, Harb S, Harding SA, Hatem R, Henriques JPS, Hildick-Smith D, Hill JM, Hoye A, Jaber W, Jaffer FA, Jang Y, Jussila R, Kalnins A, Kalyanasundaram A, Kandzari DE, Kao HL, Karmpaliotis D, Kassem HH, Khatri J, Knaapen P, Kornowski R, Krestyaninov O, Kumar AVG, Lamelas PM, Lee SW, Lefevre T, Leung R, Li Y, Li Y, Lim ST, Lo S, Lombardi W, Maran A, McEntegart M, Moses J, Munawar M, Navarro A, Ngo HM, Nicholson W, Oksnes A, Olivecrona GK, Padilla L, Patel M, Pershad A, Postu M, Qian J, Quadros A, Rafeh NA, Råmunddal T, Prakasa Rao VS, Reifart N, Riley RF, Rinfret S, Saghatelyan M, Sianos G, Smith E, Spaedy A, Spratt J, Stone G, Strange JW, Tammam KO, Thompson CA, Toma A, Tremmel JA, Trinidad RS, Ungi I, Vo M, Vu VH, Walsh S, Werner G, Wojcik J, Wollmuth J, Xu B, Yamane M, Ybarra LF, Yeh RW, Zhang Q (2021) Global chronic total occlusion crossing algorithm: JACC state-of-the-art review. J Am Coll Cardiol 24:840–853

    Article  Google Scholar 

  17. Galassi AR, Sianos G, Werner GS, Escaned J, Tomasello SD, Boukhris M, Castaing M, Büttner JH, Bufe A, Kalnins A, Spratt JC, Garbo R, Hildick-Smith D, Elhadad S, Gagnor A, Lauer B, Bryniarski L, Christiansen EH, Thuesen L, Meyer-Geßner M, Goktekin O, Carlino M, Louvard Y, Lefèvre T, Lismanis A, Gelev VL, Serra A, Marzà F, Di Mario C, Reifart N, Club ECTO (2015) Retrograde recanalization of chronic total occlusions in europe: procedural, in-hospital, and long-term outcomes from the multicenter ERCTO Registry. J Am Coll Cardiol 65:2388–2400

    Article  PubMed  Google Scholar 

  18. Megaly M, Ali A, Saad M, Omer M, Xenogiannis I, Werner GS, Karmpaliotis D, Russo JJ, Yamane M, Garbo R, Gagnor A, Ungi I, Rinfret S, Pershad A, Wojcik J, Garcia S, Mashayekhi K, Sianos G, Galassi AR, Burke MN, Brilakis ES (2019) Outcomes with retrograde versus antegrade chronic total occlusion revascularization. Catheter Cardiovasc Interv 96(5):1037–1043

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We are grateful to the members of the cardiac catheterization laboratories of the participating centers and the clinical research coordinators.

Funding

This study is funded by the Japanese board of Chronic Total Occlusion Interventional Specialist that is funded by Asahi Intecc, Abbott Vascular Japan, Biosensors Japan, Boston Scientific, Daiichi Sankyo, Kaneka Medix, Medtronic Japan, NIPRO, and Terumo.

Author information

Authors and Affiliations

  1. Department of Cardiovascular Medicine, Shinshu University School of Medicine, Matsumoto, Japan

    Soichiro Ebisawa

  2. Department of Cardiology, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki-Shi, Okayama, 710-8602, Japan

    Hiroyuki Tanaka

  3. Department of Cardiology, Tokyo Heart Center, Tokyo, Japan

    Toshiya Muramatsu

  4. Department of Cardiology, Tokushima Red Cross Hospital, Tokushima, Japan

    Koichi Kishi

  5. The Cardiovascular Institute, Tokyo, Japan

    Yuji Oikawa

  6. Division of Cardiology, Saitama Prefecture Cardiovascular and Respiratory Center, Saitama, Japan

    Makoto Muto

  7. Department of Cardiology, Seirei Hamamatsu General Hospital, Hamamatsu, Japan

    Hisayuki Okada

  8. Department of Cardiology, Shin-Koga Hospital, Fukuoka, Japan

    Tomohiro Kawasaki

  9. Director of Cardiology, Sanda City Hospital, Hyogo, Japan

    Ryohei Yoshikawa

  10. Division of Cardiology, Ootakanomori Hospital, Kashiwa, Japan

    Yuji Hamazaki

  11. Department of Cardiology, Toyohashi Heart Center, Aichi, Japan

    Etsuo Tsuchikane

  12. The Japanese CTO-PCI Expert Foundation, Okayama, Japan

    Etsuo Tsuchikane

Authors
  1. Soichiro Ebisawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hiroyuki Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Toshiya Muramatsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Koichi Kishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yuji Oikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Makoto Muto
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hisayuki Okada
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Tomohiro Kawasaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Ryohei Yoshikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Yuji Hamazaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Etsuo Tsuchikane
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hiroyuki Tanaka.

Ethics declarations

Conflict of interest

The authors declare no conflicts of interest associated with this manuscript.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ebisawa, S., Tanaka, H., Muramatsu, T. et al. Impact of minimum contrast media volumes during percutaneous coronary intervention for chronic total occlusion lesion. Heart Vessels 38, 1108–1116 (2023). https://doi.org/10.1007/s00380-023-02270-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-023-02270-9

Keywords

Search

Navigation